Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Etta, Rozen"'
Autor:
Christian Ramos-Peñafiel, Irma Olarte-Carrillo, Rafael Cerón-Maldonado, Etta Rozen-Fuller, Juan Julio Kassack-Ipiña, Guillermo Meléndez-Mier, Juan Collazo-Jaloma, Adolfo Martínez-Tovar
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Abstract Background In acute lymphoblastic leukemia (ALL), high ABCB1 gene expression has been associated with treatment resistance, which affects patient prognosis. Many preclinical reports and retrospective population studies have shown an anti-can
Externí odkaz:
https://doaj.org/article/a5d05e3bd7cc48f1bbb0e8f6f4cfcd88
Autor:
Washington Ladines-Castro, Adrián Santoyo-Sánchez, Etta Rozen-Fuller, Irma Olarte-Carrillo, Adolfo Martínez-Tovar, Humberto Castellanos-Sinco, Juan Collazo-Jaloma, Christian Omar Ramos-Peñafiel
Publikováno v:
Duazary, Vol 13, Iss 2, Pp 142-148 (2016)
In order to establish the cutoff with prognostic implications for white blood cell count and age at diagnosis in adults with acute lymphoblastic leukemia (ALL), we conducted an observational, descriptive and analytical study nested in a retrospective
Externí odkaz:
https://doaj.org/article/97f3d8cf61d6475ca934c7230ef1706d
Autor:
Etta Rozen, Anel García, Johanna Paredes, Juan Collazo, Christian Ramos, Adolfo Martinez, Juan J. Kassack, Irma Olarte, Federico Centeno, Brenda Arratia
Publikováno v:
OncoTargets and Therapy. 12:8023-8031
Objective Approximately 40-50% of patients with acute myeloid leukaemia (AML) have been reported to present with a normal karyotype and a variable disease-free period, most likely due to the molecular heterogeneity presented by these patients. A vari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::828120687d546d997262695136135328
https://doi.org/10.2147/ott.s219703
https://doi.org/10.2147/ott.s219703
Autor:
Christian Omar Ramos-Peñafiel, Álvaro Cabrera-García, Etta Rozen-Fuller, Guadalupe González-León, Carolina Balderas, Juan Julio Kassack-Ipiña, Humberto Castellanos-Sinco, Carlos Martínez-Murillo, Efreen Montaño-Figueroa, Adolfo Martínez-Tovar, Irma Olarte-Carrillo, Adrián Santoyo-Sánchez, Juan Collazo-Jaloma
Publikováno v:
Revista Peruana de Medicina Experimental y Salud Pública, Vol 31, Iss 3 (2014)
In order to assess the mortality and toxicity of the Hyper-CVAD protocol used as first-line treatment of acute lymphoblastic leukemia, a retrospective cohort study was performed in patients less than 40 years of age from March to September 2011 treat
Externí odkaz:
https://doaj.org/article/1eb20b3f48b84896a191ab030b7ef6e3
Autor:
Federico Centeno Cruz, Rafael Cerón Maldonado, Enrique Miranda Peralta, Etta Rozen Fuller, Irma Olarte Carrillo, Christian Omar Ramos Peñafiel, Juan Collazo Jaloma, Adolfo Martínez Tovar, Juan Julio Kassack Ipiña
Publikováno v:
Revista médica de Chile v.146 n.7 2018
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
Background: Metformin has antineoplastic and cancer protective effects in vitro, sensitizing leukemia cells to chemotherapeutic agents, inducing apoptosis and cell cycle arrest. Aim: To assess the effect of metformin on the induction stage in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93920f5513ef7aca157107a558c2bb74
https://doi.org/10.4067/s0034-98872018000700846
https://doi.org/10.4067/s0034-98872018000700846
Autor:
Christian Omar Ramos-Peñafiel, Humberto Castellanos-Sinco, Gilberto Barranco-Lampón, Etta Rozen-Fuller, Juan Francisco Zazueta-Pozos, Adolfo Martínez-Tovar, Adrián Santoyo-Sánchez, Efreen Horacio Montaño-Figueroa, Irma Olarte-Carrillo
Publikováno v:
Revista M�dica del Hospital General de M�xico. 82
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee4f95b2549311891d31b80a94a0f1f1
https://doi.org/10.24875/hgmx.m19000031
https://doi.org/10.24875/hgmx.m19000031
Autor:
Álvaro Cabrera-García, Lauro Fabián Amador-Medina, Roberta Demichelis-Gómez, David Gómez-Almaguer, Karla Espinosa-Bautista, Juan Carlos Solís-Poblano, Ramiro Espinoza, Lilia Adela García-Stivalet, Efreen Horacio Montaño-Figueroa, Carolina Moreira, Nidia Zapata-Canto, Erick Crespo-Solís, Etta Rozen-Fuller, Alva Zaragoza, Ramón Alejandro Martínez-Hernández, Ruth Gutiérrez-Serdán, Carolina García-Castillo, Angel Carrillo, Faustino Leyto-Cruz, Alejandro Limon, Francisco Turrubiates, Eduardo Terreros-Muñoz, Luis Meillon, Perla R. Colunga-Pedraza, Elia Ixel Apodaca, Guillermo Diaz-Vargas
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(6)
Background In the past decades, long-term survival outcomes for younger patients with acute myeloid leukemia (AML) have improved. Nonetheless, developing nations might be lagging behind, highlighting the need to assess real-world outcomes in such reg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::389c5039eb82b846679c77880a89981a
https://pubmed.ncbi.nlm.nih.gov/32192977
https://pubmed.ncbi.nlm.nih.gov/32192977
Autor:
Adolfo Martínez Tovar, Anel Irais García Laguna, Nuria Mencia-Trinchant, Monica L. Guzman, Alexandra Gomez-Arteaga, Duane C. Hassane, Irma Olarte Carrillo, Etta Rozen Fuller, Christian Omar Ramos Peñafiel
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:C061-C061
The understanding of the somatic driver mutations and genetic abnormalities in acute myeloid leukemia (AML) has enabled the discovery of actionable mutations and improved risk stratification; however, it is unclear how the distribution of molecular d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d13965c68ffcdf6041c6e9b847d5c890
https://doi.org/10.1158/1538-7755.disp18-c061
https://doi.org/10.1158/1538-7755.disp18-c061
Autor:
Juan Collazo-Jaloma, Etta Rozen-Fuller, Adolfo Martínez-Tovar, Rafael Cerón-Maldonado, Irma Olarte-Carrillo, Juan Julio Kassack-Ipiña, Guillermo Meléndez-Mier, Christian Omar Ramos-Peñafiel
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Background In acute lymphoblastic leukemia (ALL), high ABCB1 gene expression has been associated with treatment resistance, which affects patient prognosis. Many preclinical reports and retrospective population studies have shown an anti-cancer effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223d9f91bc7075ff126106d64698f162
http://europepmc.org/articles/PMC6122769
http://europepmc.org/articles/PMC6122769
Autor:
Carolina García, Eduardo Terreros, Roberta Demichelis, Elia Ixel Apodaca, Karla Espinosa, Perla Colunga, Ramiro Espinoza, Carolina Moreira, Guillermo Díaz, Ruth Gutiérrez, Ramón Martínez, Erick Crespo, David Gómez, Angel Carrillo, Francisco Turrubiates, Faustino Leyto, Alva Zaragoza, Luis Meillón, Etta Rozen, Juan_Carlos Solis, Nidia Zapata, Álvaro Cabrera, Fabián Amador, Alejandro Limon, Efreen Montaño, Lilia García
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S209-S210
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83c2349511939fb2c2184a0f56ccd131
https://doi.org/10.1016/j.clml.2019.07.074
https://doi.org/10.1016/j.clml.2019.07.074